img

Post-Traumatic Stress Disorder (PTSD) Industry: Global Market Opportunities and Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 432 | Industry : Medical Care

Publisher : MRG | Format : PDF

Post-Traumatic Stress Disorder (PTSD) Industry: Global Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Post-Traumatic Stress Disorder (PTSD) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Post-Traumatic Stress Disorder (PTSD) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Post-Traumatic Stress Disorder (PTSD) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Post-Traumatic Stress Disorder (PTSD) Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder (PTSD) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Post-Traumatic Stress Disorder (PTSD) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Post-Traumatic Stress Disorder (PTSD) industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Cognitive Therapy
Exposure Therapy
Eye Movement Desensitization And Reprocessing (EMDR)
Antidepressants
Anti-Anxiety Medications
Prazosin

Segmented by Application
Children
Adult

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Zhejiang Jianfeng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Valenta Pharm (Russia)
Tonix Pharmaceuticals Holding Corp. (US)
Prometheon Pharma (USA)
Pfizer (US)
Otsuka Pharmaceutical (Japan)
Nuvo Pharmaceuticals (Canada)
Mylan NV (US)
Marinus Pharmaceuticals, Inc. (US)
Lycera Corp (US)
Lundbeck A/S (Denmark)
Ligand Pharma (USA)
Greenstone LLC (US)
GMP Endotherapeutics (USA)
GlaxoSmithKline (UK)
Eli Lilly and Company (US)
Bionomics (Australia)
Beijing Wansheng Pharmaceutical
Azevan Pharmaceuticals (US)
Archimedes (UK)


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Status and Forecast (2016-2027)
1.3.2 Global Post-Traumatic Stress Disorder (PTSD) Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Post-Traumatic Stress Disorder (PTSD) Supply by Company
2.1 Global Post-Traumatic Stress Disorder (PTSD) Sales Value by Company
2.2 Post-Traumatic Stress Disorder (PTSD) Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Post-Traumatic Stress Disorder (PTSD) Market Status by Type
3.1 Post-Traumatic Stress Disorder (PTSD) Type Introduction
3.1.1 Cognitive Therapy
3.1.2 Exposure Therapy
3.1.3 Eye Movement Desensitization And Reprocessing (EMDR)
3.1.4 Antidepressants
3.1.5 Anti-Anxiety Medications
3.1.6 Prazosin
3.2 Global Post-Traumatic Stress Disorder (PTSD) Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Post-Traumatic Stress Disorder (PTSD) Market Status by Application
4.1 Post-Traumatic Stress Disorder (PTSD) Segment by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Post-Traumatic Stress Disorder (PTSD) Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Post-Traumatic Stress Disorder (PTSD) Market Status by Region
5.1 Global Post-Traumatic Stress Disorder (PTSD) Market by Region
5.2 North America Post-Traumatic Stress Disorder (PTSD) Market Status
5.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Status
5.4 Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Status
5.5 Central & South America Post-Traumatic Stress Disorder (PTSD) Market Status
5.6 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Status
6 North America Post-Traumatic Stress Disorder (PTSD) Market Status
6.1 North America Post-Traumatic Stress Disorder (PTSD) Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Post-Traumatic Stress Disorder (PTSD) Market Status
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Status
8.1 Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Post-Traumatic Stress Disorder (PTSD) Market Status
9.1 Central & South America Post-Traumatic Stress Disorder (PTSD) Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Status
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Post-Traumatic Stress Disorder (PTSD) Market Forecast by Type and by Application
12.1 Global Post-Traumatic Stress Disorder (PTSD) Sales Value Forecast (2022-2027)
12.2 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Type
12.3 Global Post-Traumatic Stress Disorder (PTSD) Forecast by Application
13 Global Post-Traumatic Stress Disorder (PTSD) Market Forecast by Region/Country
13.1 Global Post-Traumatic Stress Disorder (PTSD) Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Zhejiang Jianfeng Pharmaceutical
14.1.1 Company Information
14.1.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.1.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Zhejiang Huahai Pharmaceutical
14.2.1 Company Information
14.2.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.2.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Valenta Pharm (Russia)
14.3.1 Company Information
14.3.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.3.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Tonix Pharmaceuticals Holding Corp. (US)
14.4.1 Company Information
14.4.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.4.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Prometheon Pharma (USA)
14.5.1 Company Information
14.5.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.5.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Pfizer (US)
14.6.1 Company Information
14.6.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.6.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Otsuka Pharmaceutical (Japan)
14.7.1 Company Information
14.7.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.7.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Nuvo Pharmaceuticals (Canada)
14.8.1 Company Information
14.8.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.8.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Mylan NV (US)
14.9.1 Company Information
14.9.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.9.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Marinus Pharmaceuticals, Inc. (US)
14.10.1 Company Information
14.10.2 Post-Traumatic Stress Disorder (PTSD) Product Introduction
14.10.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Lycera Corp (US)
14.12 Lundbeck A/S (Denmark)
14.13 Ligand Pharma (USA)
14.14 Greenstone LLC (US)
14.15 GMP Endotherapeutics (USA)
14.16 GlaxoSmithKline (UK)
14.17 Eli Lilly and Company (US)
14.18 Bionomics (Australia)
14.19 Beijing Wansheng Pharmaceutical
14.20 Azevan Pharmaceuticals (US)
14.21 Archimedes (UK)
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Company (2019-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Post-Traumatic Stress Disorder (PTSD) Sales Area
Table Post-Traumatic Stress Disorder (PTSD) Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Type (2016-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Sals Value Market Share by Type (2016-2021)
Table North America Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Type (2016-2021)
Table North America Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Type (2016-2021)
Table Europe Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Type (2016-2021)
Table Europe Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Type (2016-2021)
Table Central & South America Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Type (2016-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Application (2016-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Value Market Share by Application (2016-2021)
Table North America Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Application (2016-2021)
Table North America Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Application (2016-2021)
Table Europe Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Application (2016-2021)
Table Europe Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Application (2016-2021)
Table Central & South America Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Sales Value Market Share by Application (2016-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Region (2016-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Value Market Share by Region (2016-2021)
Table North America Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Country (2016-2021)
Table North America Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country (2016-2021)
Table Europe Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Country (2016-2021)
Table Europe Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country (2016-2021)
Table Asia Pacific Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country (2016-2021)
Table Central & South America Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country (2016-2021)
Table Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Value Market Share by Country (2016-2021)
Table Global Post-Traumatic Stress Disorder (PTSD) Value (Million USD) Forecast by Type (2022-2027)
Table Global Post-Traumatic Stress Disorder (PTSD) Value Market Share Forecast by Type (2022-2027)
Table Global Post-Traumatic Stress Disorder (PTSD) Value (Million USD) Forecast by Application (2022-2027)
Table Global Post-Traumatic Stress Disorder (PTSD) Value Market Share Forecast by Application (2022-2027)
Table Global Post-Traumatic Stress Disorder (PTSD) Value (Million USD) Forecast by Region (2022-2027)
Table Global Post-Traumatic Stress Disorder (PTSD) Value Market Share Forecast by Region (2022-2027)
Table Zhejiang Jianfeng Pharmaceutical Company Information
Table Zhejiang Jianfeng Pharmaceutical Product Introduction
Table Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Zhejiang Huahai Pharmaceutical Company Information
Table Zhejiang Huahai Pharmaceutical Product Introduction
Table Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Valenta Pharm (Russia) Company Information
Table Valenta Pharm (Russia) Product Introduction
Table Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Tonix Pharmaceuticals Holding Corp. (US) Company Information
Table Tonix Pharmaceuticals Holding Corp. (US) Product Introduction
Table Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Prometheon Pharma (USA) Company Information
Table Prometheon Pharma (USA) Product Introduction
Table Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer (US) Company Information
Table Pfizer (US) Product Introduction
Table Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Otsuka Pharmaceutical (Japan) Company Information
Table Otsuka Pharmaceutical (Japan) Product Introduction
Table Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Nuvo Pharmaceuticals (Canada) Company Information
Table Nuvo Pharmaceuticals (Canada) Product Introduction
Table Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Mylan NV (US) Company Information
Table Mylan NV (US) Product Introduction
Table Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)
Table Marinus Pharmaceuticals, Inc. (US) Company Information
Table Marinus Pharmaceuticals, Inc. (US) Product Introduction
Table Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Sales Value, Gross Margin and Global Share (2019-2021)

Select User License

$2900 Single Licence
$4700 Enterprise Licence
$5700 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries